These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27914004)

  • 1. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
    Appiah-Kubi P; Soliman M
    Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
    Appiah-Kubi P; Soliman ME
    J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
    Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.
    Stsiapanava A; Olsson U; Wan M; Kleinschmidt T; Rutishauser D; Zubarev RA; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4227-32. PubMed ID: 24591641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
    Numao S; Hasler F; Laguerre C; Srinivas H; Wack N; Jäger P; Schmid A; Osmont A; Röthlisberger P; Houguenade J; Bergsdorf C; Dawson J; Carte N; Hofmann A; Markert C; Hardaker L; Billich A; Wolf RM; Penno CA; Bollbuck B; Miltz W; Röhn TA
    Sci Rep; 2017 Oct; 7(1):13591. PubMed ID: 29051536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A
    Teder T; König S; Singh R; Samuelsson B; Werz O; Garscha U; Haeggström JZ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic properties of leukotriene A
    Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
    Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase.
    Thangapandian S; John S; Sakkiah S; Lee KW
    J Chem Inf Model; 2011 Jan; 51(1):33-44. PubMed ID: 21133343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of novel LTA
    Low CM; Akthar S; Patel DF; Löser S; Wong CT; Jackson PL; Blalock JE; Hare SA; Lloyd CM; Snelgrove RJ
    Sci Rep; 2017 Mar; 7():44449. PubMed ID: 28303931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design.
    Thangapandian S; John S; Arooj M; Lee KW
    PLoS One; 2012; 7(4):e34593. PubMed ID: 22496831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico modeling of the molecular structure and binding of leukotriene A4 into leukotriene A4 hydrolase.
    Paz PB; Vega-Hissi EG; Estrada MR; Garro Martinez JC
    Chem Biol Drug Des; 2012 Dec; 80(6):902-8. PubMed ID: 22913921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saccharomyces cerevisiae leukotriene A4 hydrolase: formation of leukotriene B4 and identification of catalytic residues.
    Kull F; Ohlson E; Lind B; Haeggström JZ
    Biochemistry; 2001 Oct; 40(42):12695-703. PubMed ID: 11601994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.
    Poras H; Duquesnoy S; Fournié-Zaluski MC; Ratinaud-Giraud C; Roques BP; Ouimet T
    Anal Biochem; 2013 Oct; 441(2):152-61. PubMed ID: 23851339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capturing LTA
    Stsiapanava A; Samuelsson B; Haeggström JZ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9689-9694. PubMed ID: 28827365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Sonawane LV; Bari SB
    Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.
    Orning L; Krivi G; Bild G; Gierse J; Aykent S; Fitzpatrick FA
    J Biol Chem; 1991 Sep; 266(25):16507-11. PubMed ID: 1885582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Sakkiah S; Lee KW
    Eur J Med Chem; 2011 May; 46(5):1593-603. PubMed ID: 21377770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PENG: a neural gas-based approach for pharmacophore elucidation. method design, validation, and virtual screening for novel ligands of LTA4H.
    Moser D; Wittmann SK; Kramer J; Blöcher R; Achenbach J; Pogoryelov D; Proschak E
    J Chem Inf Model; 2015 Feb; 55(2):284-93. PubMed ID: 25625859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.